Radiation Oncology Concurrent Chemo-radiotherapy following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

[1]  C. Villarreal-Garza,et al.  High Frequency of Radiation Pneumonitis in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Concurrent Radiotherapy and Gemcitabine after Induction with Gemcitabine and Carboplatin , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  W. Woodward,et al.  Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. , 2008, International journal of radiation oncology, biology, physics.

[3]  L. Livi,et al.  Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma. , 2008, International journal of radiation oncology, biology, physics.

[4]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[5]  S. Paik,et al.  Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Tiezzi,et al.  HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination , 2007, BMC Cancer.

[7]  G. Calais,et al.  Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Qifeng Yang,et al.  Concurrent chemo-radiation in the conservative management of breast cancer. , 2006, International journal of radiation oncology, biology, physics.

[9]  M. Bollet,et al.  Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study. , 2006, European journal of cancer.

[10]  A. C. García-Ulloa,et al.  Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer , 2006, Medical oncology.

[11]  C. Grau,et al.  Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  G. Hortobagyi,et al.  Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. Bhosle,et al.  Potential of radiosensitizing agents in cancer chemo-radiotherapy. , 2005, Journal of cancer research and therapeutics.

[14]  G. Hortobagyi,et al.  Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[15]  A. Mohar,et al.  Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study. , 2005, International journal of radiation oncology, biology, physics.

[16]  John J Spinelli,et al.  Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. , 2005, Journal of the National Cancer Institute.

[17]  A. Luini,et al.  Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors , 2004, Clinical Cancer Research.

[18]  J. Hayman,et al.  A Phase I Dose Escalation Trial of Gemcitabine with Radiotherapy for Breast Cancer in the Treatment of Unresectable Chest Wall Recurrences , 2004, The breast journal.

[19]  A. Dueñas-González,et al.  Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  S. Giordano,et al.  Update on locally advanced breast cancer. , 2003, The oncologist.

[21]  S. Edge,et al.  Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. , 2003, The Surgical clinics of North America.

[22]  I. Tannock,et al.  Concurrent cyclophosphamide, methotrexate, and 5‐fluorouracil chemotherapy and radiotherapy for breast carcinoma , 2002, Cancer.

[23]  Henry M Kuerer,et al.  Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. , 2002, International journal of radiation oncology, biology, physics.

[24]  C. V. D. van de Velde,et al.  Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Y. Kirova,et al.  Long‐term results of neoadjuvant radiation therapy for breast cancer , 2001, International journal of cancer.

[26]  S. Kudoh,et al.  Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  J. Cooper,et al.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. , 1999, JAMA.

[28]  M. Leblanc,et al.  Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  M. Fukuoka,et al.  294 A randomized phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with mitomycin (M), vindesine (V), and cisplatin (P) in unresectable stage III non-small cell lung cancer (NSCLC): Preliminary analysis , 1997 .

[30]  V. Semiglazov,et al.  Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  A. Luini,et al.  Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. , 1990, Journal of the National Cancer Institute.

[32]  G. Hortobagyi,et al.  Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy , 1988, Cancer.

[33]  V. Vaitkevicius,et al.  Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal , 1981, Cancer.

[34]  F. Baclesse.  Five‐Year Results in 431 Breast Cancers Treated Solely by Roentgen Rays , 1965, Annals of surgery.

[35]  A. Luini,et al.  Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[36]  M. Chávez-MacGregor,et al.  Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: a case–control analysis , 2005, Breast Cancer Research and Treatment.

[37]  M. Brennan,et al.  Locally advanced and inflammatory breast cancer. , 2005, Australian family physician.

[38]  P. Scalliet,et al.  Gemzar (Gemcitabine) with thoracic radiotherapy- A phase II pilot study in chemonaive patients with advanced non-small cell lung cancer (NSCLC) [abstract] , 1998 .

[39]  G. Murphy.  The national cancer data base , 1991, CA: a cancer journal for clinicians.